Update of the Pompe variant database for the prediction of clinical phenotypes: Novel disease‐associated variants, common sequence variants, and results from newborn screening
Open Access
- 8 December 2020
- journal article
- research article
- Published by Wiley in Human Mutation
- Vol. 42 (2) , 119-134
Abstract
Pompe disease is an inherited disorder caused by disease‐associated variants in the acid α‐glucosidase gene (GAA). The Pompe disease GAA variant database (http://www.pompevariantdatabase.nl) is a curated, open source, disease‐specific database and lists disease‐associated GAA variants, in silico predictions, and clinical phenotypes reported until 2016. Here we provide an update to include 226 disease‐associated variants that were published until 2020. We also listed 148 common GAA sequence variants that do not cause Pompe disease. GAA variants with unknown severity that were identified only in newborn screening programs were listed as a new feature to indicate the reason why phenotypes were still unknown. Expression studies were performed for common missense variants to predict their severity. The updated Pompe disease GAA variant database now includes 648 disease‐associated variants, 26 variants from newborn screening, and 237 variants with unknown severity. Regular updates of the Pompe disease GAA variant database will be required to improve genetic counseling and the study of genotype‐phenotype relationships.Keywords
This publication has 38 references indexed in Scilit:
- Assessment of the functional impact on the pre‐mRNA splicing process of 28 nucleotide variants associated with Pompe disease in GAA exon 2 and their recovery using antisense technologyHuman Mutation, 2019
- Newborn screening: Taiwanese experienceAnnals of Translational Medicine, 2019
- A genetic modifier of symptom onset in Pompe diseaseEBioMedicine, 2019
- Newborn screening for lysosomal storage disorders by tandem mass spectrometry in North East ItalyJournal of Inherited Metabolic Disease, 2017
- Investigation of newborns with abnormal results in a newborn screening program for four lysosomal storage diseases in BrazilMolecular Genetics and Metabolism Reports, 2017
- Newborn Screening for Pompe DiseasePediatrics, 2017
- New mutations and genotype–phenotype correlation in late-onset Pompe patientsActa Neurologica Belgica, 2016
- Pilot study of newborn screening for six lysosomal storage diseases using Tandem Mass SpectrometryMolecular Genetics and Metabolism, 2016
- Predicting cross‐reactive immunological material (CRIM) status in Pompe disease using GAA mutations: Lessons learned from 10 years of clinical laboratory testing experienceAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2012
- Later-Onset Pompe Disease: Early Detection and Early Treatment Initiation Enabled by Newborn ScreeningThe Journal of Pediatrics, 2011